novel car t-cell therapies for hematological malignancies: exploring new targets
Published 7 months ago • 81 plays • Length 4:17Download video MP4
Download video MP3
Similar videos
-
1:49
a novel subcutaneous car-t therapy for the treatment of hematological malignancies
-
0:49
novel targets for car-t therapy in mcl
-
1:09
the promise of car t-cell therapy in hematological malignancies
-
1:10
tackling resistance to car-t therapy across hematological malignancies
-
2:48
the novel icaht grading system to predict toxicity following car t-cell therapy
-
1:06
novel third-generation tlr2 co-stimulatory car-t cells for b-cell malignancies
-
4:23
novel strategies to optimize car t-cell therapy
-
2:05
novel car-t constructs being explored in myeloma: t-charge platform
-
11:18
car-t cells: engineered cancer killers
-
16:43
engineering better car t cells: an interview with cri star yvonne chen, phd
-
15:02
car t-cell therapy in aml: state of the art
-
1:34
cctx-001: a novel car-t therapy for aml
-
1:06
car-t cell therapy: current applications and how to improve treatment strategies in the future
-
0:54
ucartcs1: a novel allogeneic car-t therapy for myeloma
-
3:33
an overview of the car t-cell therapy story
-
1:26
an insight into ctx130: a novel allogeneic car-t cell therapy
-
3:43
the future of car-t therapy
-
1:59
novel car-t constructs being investigated for the treatment of all
-
1:16
the efficacy of car t-cell therapy in richter’s transformation
-
4:24
investigating production failure and out-of-specification production of car t-cell therapeutics
-
1:12
novel all treatment strategies: car t-cells
-
2:09
the financial burden of car t-cell therapy